Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aggressive B-cell Lymphomas”

242 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 242 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05458297
What this trial is testing

Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)

Who this might be right for
Chronic Lymphocytic LeukemiaMantle Cell LymphomaFollicular Lymphoma+1 more
Merck Sharp & Dohme LLC 223
Testing effectiveness (Phase 2)Study completedNCT01582776
What this trial is testing

Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Relapsed/Refractory Follicular and Aggressive B-cell Lymphoma

Who this might be right for
Follicular Lymphoma Patients (Phase IB)Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)
The Lymphoma Academic Research Organisation 317
Testing effectiveness (Phase 2)Study completedNCT00290667
What this trial is testing

Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma

Who this might be right for
Lymphoma
German High-Grade Non-Hodgkin's Lymphoma Study Group 586
Large-scale testing (Phase 3)Study completedNCT01231412
What this trial is testing

Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+16 more
Fred Hutchinson Cancer Center 174
Testing effectiveness (Phase 2)Looking for participantsNCT07097363
What this trial is testing

Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Non-Hodgkin LymphomaBurkitt LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise Specified+6 more
University of Washington 18
Early research (Phase 1)Ended earlyNCT03864419
What this trial is testing

Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda

Who this might be right for
Burkitt LymphomaKSHV-associated Multicentric Castleman DiseaseDiffuse Large B-Cell Lymphoma
Fred Hutchinson Cancer Center 18
Early research (Phase 1)Study completedNCT03527147
What this trial is testing

Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)

Who this might be right for
NHLDLBCLNon-hodgkin's Lymphoma+1 more
Acerta Pharma BV 30
Testing effectiveness (Phase 2)Looking for participantsNCT06238648
What this trial is testing

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

Who this might be right for
Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedPrimary Mediastinal Large B-Cell LymphomaTransformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Academic and Community Cancer Research United 120
Very early researchStudy completedNCT02846935
What this trial is testing

P53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies

Who this might be right for
T-cell LymphomaAggressive B-cell LymphomaNon-Hodgkin's Lymphomas+1 more
Yogen Saunthararajah 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT03038672
What this trial is testing

Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas

Who this might be right for
ALK-Positive Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma Activated B-Cell TypeDiffuse Large B-Cell Lymphoma Associated With Chronic Inflammation+32 more
National Cancer Institute (NCI) 54
Not applicableLooking for participantsNCT06550427
What this trial is testing

Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing

Who this might be right for
LymphomaHodgkin LymphomaT-cell Lymphoma+1 more
National Taiwan University Hospital 200
Early research (Phase 1)Study completedNCT00794638
What this trial is testing

A Phase I Clinical Trial of SyB L-0501 in Combination With Rituximab to Patients With Aggressive B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaDiffuse Large B-Cell LymphomaMantle Cell Lymphoma+1 more
SymBio Pharmaceuticals 9
Early research (Phase 1)Looking for participantsNCT04884035
What this trial is testing

Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma

Who this might be right for
Lymphoma, B-Cell
Celgene 224
Early research (Phase 1)Active Not RecruitingNCT05020678
What this trial is testing

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers

Who this might be right for
Lymphoma, Non-HodgkinB-cell Acute Lymphoblastic LeukemiaLarge B-cell Lymphoma+7 more
Nkarta, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT00987493
What this trial is testing

Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell Lymphoma

Who this might be right for
Lymphoma
Swiss Cancer Institute 49
Large-scale testing (Phase 3)Study completedNCT00005867
What this trial is testing

Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Lymphoma Trials Office 310
Early research (Phase 1)Study completedNCT01231919
What this trial is testing

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT00723099
What this trial is testing

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+23 more
Fred Hutchinson Cancer Center 73
Testing effectiveness (Phase 2)Study completedNCT00842595
What this trial is testing

Efficacy , Safety of Treatment R NIMP for Relapsed Aggressive Lymphomas

Who this might be right for
Diffuse Large B-Cell Lymphoma
French Innovative Leukemia Organisation 50
Early research (Phase 1)Active Not RecruitingNCT05206357
What this trial is testing

Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

Who this might be right for
Non-hodgkin Lymphoma
Genmab 17
Load More Results